Merk Strategy
MERCK & COMPANY INC
Kady Doyle
Rudy Hsieh
Eunkyung Jun
Joey Petrella
Mastura Zaini
Table of Contents 2
Overview of Merck & Co Inc. 3 Case Abstract 4 History 5 Timeline of Important Milestones 5
Vision Statement 7
Mission Statement 7
Opportunities 9
Threats 9
External Factor Evaluation (EFE) Matrix 9
CPM 11 Internal Audit 12
Strengths 13
Weaknesses 13
Financial Ratio Analysis 13 Company and Industry Performance 14
Internal Factor Evaluation (IFE) Matrix 17 SWOT Matrix 18 SPACE Matrix 21 Grand Strategy Matrix 24 The Internal-External (IE) Matrix 26 Balanced Score Card (Figure 1) 28 Balanced Scorecard 28 Benchmarking 28 Outsourcing 29 QSPM 31 Recommendations 33 EPS / EBIT Analysis 36 Epilogue 37
Overview of Merck & Co Inc.
Case Abstract
Merck and Company Inc. was incorporated in New Jersey and trades on the New York Stock Exchange (NYSE: MRK). It is a research-driven pharmaceutical company that discovers, develops, manufactures and markets a broad range of products used to improve consumer and animal health, generating sales of $27.4 billion with an operating profit of $2.4 billion as December 31, 2009.
Headquartered in Whitehouse Station, N.J., Merck provides its products through wholesale, retail drug and food chain, and mass merchandiser outlets in the United States and worldwide. In addition, the company has production facilities for its human health products at locations in the United States, Puerto Rico, as well as plants in Australia, Canada, Japan, Singapore, South Africa and other countries in Western Europe, Central and South America, and Asia.
The company operates in three segments: the pharmaceutical, animal health and consumer healthcare segments. The Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in various areas across the body. The Animal Health segment offers
Kady Doyle
Rudy Hsieh
Eunkyung Jun
Joey Petrella
Mastura Zaini
Table of Contents 2
Overview of Merck & Co Inc. 3 Case Abstract 4 History 5 Timeline of Important Milestones 5
Vision Statement 7
Mission Statement 7
Opportunities 9
Threats 9
External Factor Evaluation (EFE) Matrix 9
CPM 11 Internal Audit 12
Strengths 13
Weaknesses 13
Financial Ratio Analysis 13 Company and Industry Performance 14
Internal Factor Evaluation (IFE) Matrix 17 SWOT Matrix 18 SPACE Matrix 21 Grand Strategy Matrix 24 The Internal-External (IE) Matrix 26 Balanced Score Card (Figure 1) 28 Balanced Scorecard 28 Benchmarking 28 Outsourcing 29 QSPM 31 Recommendations 33 EPS / EBIT Analysis 36 Epilogue 37
Overview of Merck & Co Inc.
Case Abstract
Merck and Company Inc. was incorporated in New Jersey and trades on the New York Stock Exchange (NYSE: MRK). It is a research-driven pharmaceutical company that discovers, develops, manufactures and markets a broad range of products used to improve consumer and animal health, generating sales of $27.4 billion with an operating profit of $2.4 billion as December 31, 2009.
Headquartered in Whitehouse Station, N.J., Merck provides its products through wholesale, retail drug and food chain, and mass merchandiser outlets in the United States and worldwide. In addition, the company has production facilities for its human health products at locations in the United States, Puerto Rico, as well as plants in Australia, Canada, Japan, Singapore, South Africa and other countries in Western Europe, Central and South America, and Asia.
The company operates in three segments: the pharmaceutical, animal health and consumer healthcare segments. The Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in various areas across the body. The Animal Health segment offers